|
1.
|
Hunt CM, Watkins PB, Saenger P, et al:
Heterogeneity of CYP3A isoforms metabolizing erythromycin and
cortisol. Clin Pharmacol Ther. 51:18–23. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ghosh S, Grogan WM, Basu A and Watlington
C: Renal corticosterone 6 beta-hydroxylase in the spontaneously
hypertensive rat. Biochim Biophys Acta. 1182:152–156. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Watlington CO, Kramer LB, Schuetz EG, et
al: Corticosterone 6 beta-hydroxylation correlates with blood
pressure in spontaneously hypertensive rats. Am J Physiol.
262:F927–F931. 1992.PubMed/NCBI
|
|
4.
|
Kuehl P, Zhang J, Lin Y, Lamba J, et al:
Sequence diversity in CYP3A promoters and characterization of the
genetic basis of polymorphic CYP3A5 expression. Nat Genet.
27:383–391. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Huang W, Lin YS, McConn DJ II, et al:
Evidence of significant contribution from CYP3A5 to hepatic drug
metabolism. Drug Metab Dispos. 32:1434–1445. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bolbrinker J, Seeberg S, Schostak M, et
al: CYP3A5 genotype-phenotype analysis in the human kidney reveals
a strong site-specific expression of CYP3A5 in the proximal tubule
in carriers of the CYP3A5*1 allele. Drug Metab Dispos. 40:639–641.
2012.PubMed/NCBI
|
|
7.
|
Haehner BD, Gorski JC, Vandenbranden M, et
al: Bimodal distribution of renal cytochrome P450 3A activity in
humans. Mol Pharmacol. 50:52–59. 1996.PubMed/NCBI
|
|
8.
|
Duncan RL, Grogan WM, Kramer LB and
Watlington CO: Corticosterone’s metabolite is an agonist for
Na+ transport stimulation in A6 cells. Am J Physiol.
255:F736–F748. 1988.
|
|
9.
|
Grogan WM, Fidelman ML, Newton DE, et al:
A corticosterone metabolite produced by A6 (toad kidney) cells in
culture: identification and effects on Na+ transport.
Endocrinology. 116:1189–1194. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Koch I, Weil R, Wolbold R, et al:
Interindividual variability and tissue-specificity in the
expression of cytochrome P450 3A mRNA. Drug Metab Dispos.
30:1108–1114. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Xi B, Wang C, Liu L, et al: Association of
the CYP3A5 polymorphism (6986G>A) with blood pressure and
hypertension. Hypertens Res. 34:1216–1220. 2011.
|
|
12.
|
Langaee TY, Gong Y, Yarandi HN, et al:
Association of CYP3A5 polymorphisms with hypertension and
antihypertensive response to verapamil. Clin Pharmacol Ther.
81:386–391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Eap CB, Bochud M, Elston RC, et al: CYP3A5
and ABCB1 genes influence blood pressure and response to treatment,
and their effect is modified by salt. Hypertension. 49:1007–1014.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Givens RC, Lin YS, Dowling AL, et al:
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in
healthy adults. J Appl Physiol. 95:1297–1300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhang L, Miyaki K, Wang W and Muramatsu M:
CYP3A5 polymorphism and sensitivity of blood pressure to dietary
salt in Japanese men. J Hum Hypertens. 24:345–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Rais N, Chawla YK and Kohli KK: CYP3A
phenotypes and genotypes in North Indians. Eur J Clin Pharmacol.
62:417–422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Daly AK, Steen VM, Fairbrother KS and Idle
JR: CYP2D6 multiallelism. Methods Enzymol. 272:199–210. 1996.
View Article : Google Scholar
|
|
18.
|
Balram C, Zhou Q, Cheung YB and Lee EJ:
CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct
Asian populations. Eur J Clin Pharmacol. 59:123–126. 2003.
|
|
19.
|
Aoyama T, Yamano S, Waxman DJ, et al:
Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product
that is differentially expressed in adult human liver. cDNA and
deduced amino acid sequence and distinct specificities of
cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid
hormones and cyclosporine. J Biol Chem. 264:10388–10395. 1989.
|
|
20.
|
Mugundu GM, Sallans L, Guo Y, et al:
Assessment of the impact of CYP3A polymorphisms on the formation of
α-hydroxytamoxifen and N-desmethyltamoxifen in human liver
microsomes. Drug Metab Dispos. 40:389–396. 2012.
|
|
21.
|
Daly AK: Significance of the minor
cytochrome P450 3A isoforms. Clinic Pharmacokinet. 45:13–31. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kamdem LK, Streit F, Zanger UM, et al:
Contribution of CYP3A5 to the in vitro hepatic clearance of
tacrolimus. Clin Chem. 51:1374–1381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Givens RC, Lin YS, Dowling AL, et al:
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in
healthy adults. J Appl Physiol. 95:1297–1300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kornel L, Miyabo S, Saito Z, et al:
Corticosteroids in human blood. VIII Cortisol metabolites in plasma
of normotensive subjects and patients with essential hypertension.
J Clin Endocrinol Metab. 40:949–958. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Ho H, Pinto A, Hall SD, et al: Association
between the CYP3A5 genotype and blood pressure. Hypertension.
45:294–298. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Cornoni-Huntley J, LaCroix AZ and Havlik
RJ: Race and sex differentials in the impact of hypertension in the
United States. The National Health and Nutrition Examination Survey
I Epidemiologic Follow-up Study. Arch Intern Med. 149:780–788.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Weinberger MH: Salt sensitivity of blood
pressure in humans. Hypertension. 27:481–490. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Xie HG, Wood AJ, Kim RB, et al: Genetic
variability in CYP3A5 and its possible consequences.
Pharmacogenomics. 5:243–272. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lamba JK, Dhiman RK and Kohli KK: CYP2C19
genetic mutations in North Indians. Clin Pharmacol Ther.
68:328–335. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Adithan C, Gerard N, Vasu S, et al: Allele
and genotype frequency of CYP2C19 in a Tamilian population. Br J
Clin Pharmacol. 56:331–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
